Secretome Therapy, Potential Treatment for Rotator Cuff Tear: A Case Study
Article Sidebar
Main Article Content
Abstract
Introduction: Rotator cuff tears (RCTs) are the most frequent pathologies within the shoulder girdle, and this injury is the most commonly diseased tendons in the human body. RCTs can cause pain and weakness in the shoulder. A 42-year-old woman had right shoulder pain and arm lift problems for almost a year. Ultrasonography revealed a full-thickness Supraspinatus tear. The patient underwent an Ultrasound-guided supraspinatus tendon injection of 2 ml umbilical cord Mesenchymal Stem Cell (MSC) secretome.
Methods: This is a case report analyzing the role of secretome therapy in rotator cuff tear potential treatment. The study was conducted at RSCM Hospital.
Results: At the one-week follow-up, the patient's Shoulder Pain and Disability Index (SPADI) score decreased from 56,9% to 48,5%, her pain scale reduced from 8 to 6, and her shoulder Active Range of Motion (AROM) improved. After a month, there was an improvement in her shoulder AROM. However, the ultrasound shows no significant improvement in the supraspinatus tear structure after the secretome injection.
Conclusion: Secretome has a potential effect on reducing pain and improving functional outcomes in rotator cuff tears. These findings raise the prospect of secretome as a potential regenerative therapy for rotator cuff tears.
Keywords: mesenchymal stem cells conditioned-medium, rotator cuff tear, secretome, supraspinatus tear.
Article Details
Section
All articles published in the Indonesian Journal of Physical Medicine and Rehabilitation (IJPMR) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to share, copy, distribute, adapt, and build upon the work for any purpose, including commercial use, as long as proper attribution is given to the original authors.
Indonesian Journal of Physical Medicine and Rehabilitation is Full license terms: https://creativecommons.org/licenses/by/4.0/
How to Cite
References
Jeong J, Park S, Ji J, Lee H, Jung S, Choi B. Trans-tendon suture bridge rotator cuff repair with tenotomized pathologic biceps tendon augmentation in high-grade PASTA lesions. Arch Orthop Traum Surg. 2020;140:67-76. DOI: https://doi.org/10.1007/s00402-019-03285-6
Rho JY, Kwon Y suk, Choi S. Current Concepts and Recent Trends in Arthroscopic Treatment of Large to Massive Rotator Cuff Tears: A Review. Clin Shoulder Elb. 2019 Mar 1;22(1):50–7. DOI: https://doi.org/10.5397/cise.2019.22.1.50
Mera BJ. Current Perspectives on Rotator Cuff Disease. Osteology. 2022 Jun;2(2):62–9. DOI: https://doi.org/10.3390/osteology2020007
Wani Z, Abdulla M, Habeebullah A, Kalogriantis S. Rotator cuff tears: Review of epidemiology, clinical assessment and operative treatment. Trauma [Internet]. 2016 Jul;18(3):190–204. Available from: http://dx.doi.org/10.1177/1460408615596770 DOI: https://doi.org/10.1177/1460408615596770
Gaspar D, Spanoudes K, Holladay C et al. Progress in cell-based therapies for tendon repair. Adv Drug Deliv Rev 2015;84:240–256. DOI: https://doi.org/10.1016/j.addr.2014.11.023
Docheva D, Muller SA, Majewski M et
al.Biologics for tendon repair. Adv Drug Deliv Rev 2015;84:222–239. DOI: https://doi.org/10.1016/j.addr.2014.11.015
Sharma S, Bhattacharyya S, Mahajan A. Potential application of mesenchymal stem cells and their secretory factors for musculoskeletal
disorders: A brief review. J Postgrad Med Educ Res [Internet]. 2018 Jun;52(2):73–82. Available from: https://www.jpmer.com/doi/10.5005/j
p-journals-10028-1279
He J, Ping S, Yu F, Yuan X, Wang J,Qi J. Mesenchymal stem cell-derived exosomes: therapeutic implications for rotator cuff injury. Regen Med[Internet]. 2021 Aug;16(8):803–15. Available from:http://dx.doi.org/10.2217/rme-2020- DOI: https://doi.org/10.2217/rme-2020-0183
Whittle S, Buchbinder R, Cotton D,Rao JK, Taichman D, Williams S.Rotator Cuff Disease. Ann Intern Med.2015 Jan 6;162(1):ITC1–16. DOI: https://doi.org/10.7326/AITC201501060
Edmonds EW, Dengerink DD.Common conditions in the overhead athlete. Am Fam Physician.2014;89(7):537-541.
Valencia Mora M, Ruiz Iban MA, Diaz Heredia J, Barco Laakso R, Cuellar R,Garcia Arranz M. Stem cell therapy in the management of shoulder rotator cuff disorders. World J Stem Cells. 2015;7(4):691-9. DOI: https://doi.org/10.4252/wjsc.v7.i4.691
Ruiz-Alonso S, Lafuente-Merchan M,Ciriza J, Saenz-del-Burgo L, Pedraz JL. Tendon tissue engineering: Cells, growth factors, scaffolds and production techniques. J Controlled Release. 2021 May 10;333:448–86. DOI: https://doi.org/10.1016/j.jconrel.2021.03.040
Degen RM, Carbone A, Carballo C,Zong J, Chen T, Lebaschi A, et al. The Effect of Purified Human Bone
Marrow–Derived Mesenchymal Stem Cells on Rotator Cuff Tendon Healing in an Athymic Rat. Arthrosc J Arthrosc Relat Surg. 2016 Dec 1;32(12):2435–43. DOI: https://doi.org/10.1016/j.arthro.2016.04.019
Park GY, Kwon DR, Lee SC.Regeneration of Full-Thickness
Rotator Cuff Tendon Tear After Ultrasound-Guided Injection With Umbilical Cord Blood-Derived Mesenchymal Stem Cells in a Rabbit Model. Stem Cells Transl Med. 2015 Nov 1;4(11):1344–51. DOI: https://doi.org/10.5966/sctm.2015-0040
Kwon DR, Park GY, Lee SC. Regenerative effects of mesenchymal
stem cells by dosage in a chronic rotator cuff tendon tear in a rabbit model. Regen Med. 2019 Nov;14(11):1001–12. DOI: https://doi.org/10.2217/rme-2018-0125
Yea JH, Bae TS, Kim BJ, Cho YW, JoCH. Regeneration of the rotator cuff tendon-to-bone interface using umbilical cord-derived mesenchymal stem cells and gradient extracellular matrix scaffolds from adipose tissue in a rat model. Acta Biomater. 2020 Sep DOI: https://doi.org/10.2139/ssrn.3582153
;114:104–16.
Beeravolu N, Khan I, McKee C, Dinda S, Thibodeau B, Wilson G, et al.Isolation and comparative analysis of
potential stem/progenitor cells from different regions of human umbilical cord. Stem Cell Res. 2016 May 1;16(3):696–711. DOI: https://doi.org/10.1016/j.scr.2016.04.010
Li M, Luan F, Zhao Y, Hao H, Liu J, Dong L, et al. Mesenchymal stem cell- conditioned medium accelerates wound healing with fewer scars. Int Wound J. 2017;14(1):64–73. DOI: https://doi.org/10.1111/iwj.12551
Chen HS, Yau YC, Ko PT, Yen BLJ, Ho CT, Hung SC. Mesenchymal Stem Cells From a Hypoxic Culture Can Improve Rotator Cuff Tear Repair.
Cell Transplant. 2022 Jan 1;31:09636897221089633.
Kwon DR, Park GY. Adult mesenchymal stem cells for the treatment in patients with rotator cuff disease: present and future direction.
Ann Transl Med. 2018 Nov;6(22):432–432. DOI: https://doi.org/10.21037/atm.2018.09.06
Rak Kwon D, Jung S, Jang J, Park GY, Suk Moon Y, Lee SC. A 3-Dimensional Bioprinted Scaffold With
Human Umbilical Cord Blood–Mesenchymal Stem Cells Improves Regeneration of Chronic Full- Thickness Rotator Cuff Tear in a Rabbit Model. Am J Sports Med. 2020 Mar 1;48(4):947–58. DOI: https://doi.org/10.1177/0363546520904022
Bari E, Perteghella S, Catenacci L, Sorlini M, Croce S, Mantelli M, et al. Freeze-dried and GMP-compliant pharmaceuticals containing exosomes for acellular mesenchymal stromal cell immunomodulant therapy. Nanomed. 2019 Mar;14(6):753– DOI: https://doi.org/10.2217/nnm-2018-0240